Hiroshi Miura is a Shareholder in the Tokyo office with over 20 years of deep experience navigating complex, cross-border Mergers and Acquisitions. Recognized for his strategic approach and commercial acumen, Hiroshi serves as a trusted advisor to a diverse portfolio of premier clients, including top-tier private equity funds, Japanese multinational corporations, and leading global enterprises.
Hiroshi boasts a truly global transaction record. His broad M&A practice covers the acquisition of both private and public companies within Japan. Globally, Hiroshi has successfully guided clients through complex cross-border deals, including tender offers for both private and publicly traded companies in the United States, as well as the strategic acquisition of listed entities in Hong Kong and the United Kingdom.
Beyond core M&A execution, Hiroshi provides comprehensive counsel on related financial structuring, possessing deep experience in acquisition finance, equity finance, and broader corporate finance matters. Furthermore, Hiroshi is highly skilled in navigating the complexities of antitrust and competition laws, particularly within heavily regulated industries. With a profound understanding of regulatory frameworks, he frequently negotiates with regulatory authorities, seeking to ensure seamless transaction approvals and drive deals to successful closures.
A significant pillar of Hiroshi’s practice is dedicated to the health care sector. Leveraging a deep knowledge of healthcare regulations and compliance, he has orchestrated and executed a wide array of M&A transactions for pharmaceutical, medical device, and broader health care companies, guiding them through the industry's unique legal landscape.
Hiroshi is highly regarded by the clients he serves. Reflecting a steadfast commitment to exceptional legal service and client success, Hiroshi was recently named to the 2026 Thomson Reuters Stand-out List, an exclusive accolade awarded based entirely on direct nominations and recommendations from clients.
Recognition & Leadership
Awards & Accolades
•Listed, Thomson Reuters, “Stand-Out Lawyers,” 2026